- Added to Email Alerts
Psoriasis
Latest News View All
-
EULAR 2021Risankizumab Shows Efficacy, Tolerability in Patients With PsA -
EULAR 2021GRAPPA Refines Recommendations on Psoriatic Disease Treatment
-
AlertSecukinumab, IL-17 Inhibitor, Approved for Pediatric Psoriasis
-
COVID Vax Response Low in Immune-Mediated Inflammatory Diseases
-
Lawmakers Allege AbbVie Exploits US Patents to Protect Humira Profits
-
Drug Monitoring Has Little Value During Infliximab Induction
-
TNFi Linked to Threefold Higher Psoriasis Risk in JIA Patients
-
Studies Add to Knowledge Base of Biosimilars for Psoriasis, HS
Perspective View All
Journal Articles View All
-
Secukinumab 2-weekly vs. 4-weekly Dosing in Plaque Psoriasis
-
Certolizumab Pegol in Psoriasis: Considerations for Pregnancy
-
The Genitourinary Syndrome of Menopause
-
A Decade of Next-generation Sequencing in Genodermatoses
-
Apremilast and Deployability in Soldiers With PsO and PsA
-
Secukinumab Shows High, Sustained Efficacy in Nail Psoriasis
Additional Resources
Medscape Drugs & Diseases
Medscape Education